Back to Search Start Over

423P Fruquintinib plus sintilimab in refractory repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Preliminary clinical results and biomarker analyses from a phase II study.

Authors :
Zhang, W.
Sun, Y.
Jiang, Z.
Liu, T.
Gong, C.
Yang, L.
Xin, Y.
Huang, D.
Zhou, A.
Source :
Annals of Oncology. 2022 Supplement 7, Vol. 33, pS728-S728. 1p.
Publication Year :
2022

Subjects

Subjects :
*COLORECTAL cancer
*METASTASIS
*BIOMARKERS

Details

Language :
English
ISSN :
09237534
Volume :
33
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
159077356
Full Text :
https://doi.org/10.1016/j.annonc.2022.07.561
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details